{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:32:26Z","timestamp":1791639146854,"version":"4.3.4"},"reference-count":88,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"am","delay-in-days":377,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["ZIA DK043006-46"],"award-info":[{"award-number":["ZIA DK043006-46"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.beem.2025.101984","type":"journal-article","created":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T16:16:03Z","timestamp":1740845763000},"page":"101984","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Heritable hyperparathyroidism: Genetic insights and clinical implications"],"prefix":"10.1016","volume":"39","author":[{"given":"Ashna","family":"Grover","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.beem.2025.101984_bib1","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1210\/endrev\/bnad009","article-title":"Molecular and clinical spectrum of primary hyperparathyroidism","volume":"44","author":"Jha","year":"2023","journal-title":"Endocr Rev"},{"issue":"1","key":"10.1016\/j.beem.2025.101984_bib2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.6061\/clinics\/2012(Sup01)23","article-title":"Primary hyperparathyroidism in multiple endocrine neoplasia type 1: when to perform surgery?","volume":"67","author":"Giusti","year":"2012","journal-title":"Clinics"},{"key":"10.1016\/j.beem.2025.101984_bib3","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3389\/fendo.2019.00339","article-title":"Multiple Endocrine Neoplasia Type 1 (MEN1): an update and the significance of early genetic and clinical diagnosis","volume":"10","author":"Kamilaris","year":"2019","journal-title":"Front Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2025.101984_bib4","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s12020-017-1322-5","article-title":"MEN1 in children and adolescents: data from patients of a regional referral center for hereditary endocrine tumors","volume":"59","author":"Vannucci","year":"2018","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.beem.2025.101984_bib5","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1245\/s10434-015-4865-9","article-title":"Limited parathyroidectomy in Multiple Endocrine Neoplasia Type 1-associated primary hyperparathyroidism: a setup for failure","volume":"23","author":"Nilubol","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.beem.2025.101984_bib6","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1210\/jc.2012-1230","article-title":"Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1)","volume":"97","author":"Thakker","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2025.101984_bib7","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1097\/SLA.0b013e31824c5145","article-title":"Primary hyperparathyroidism in MEN1 patients: a cohort study with longterm follow-up on preferred surgical procedure and the relation with genotype","volume":"255","author":"Pieterman","year":"2012","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.beem.2025.101984_bib8","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0016-5107(92)70571-9","article-title":"Regression of duodenal gastrinomas in a patient with multiple endocrine neoplasia type I after parathyroidectomy","volume":"38","author":"Mai","year":"1992","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"10.1016\/j.beem.2025.101984_bib9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1530\/EJE-12-0117","article-title":"MEN1-related hyperparathyroidism: response to cinacalcet and its relationship with the calcium-sensing receptor gene variant Arg990Gly","volume":"167","author":"Filopanti","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.beem.2025.101984_bib10","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.beem.2018.09.006","article-title":"Non-surgical management of primary hyperparathyroidism","volume":"32","author":"Cetani","year":"2018","journal-title":"Best Pr Res Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2025.101984_bib11","doi-asserted-by":"crossref","DOI":"10.1530\/EC-22-0411","article-title":"Multiple endocrine neoplasia type 4: a new member of the MEN family","volume":"12","author":"Singeisen","year":"2023","journal-title":"Endocr Connect"},{"issue":"1","key":"10.1016\/j.beem.2025.101984_bib12","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-22-0174","article-title":"Germline CDKN1B variant type and site are associated with phenotype in MEN4","volume":"30","author":"Halperin","year":"2023","journal-title":"Endocr Relat Cancer"},{"issue":"9","key":"10.1016\/j.beem.2025.101984_bib13","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1210\/jc.2019-00082","article-title":"Clinical Features of Multiple Endocrine Neoplasia Type 4: novel pathogenic variant and review of published cases","volume":"104","author":"Frederiksen","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2025.101984_bib14","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.beem.2025.101984_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/humu.21385","article-title":"Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10","volume":"32","author":"Frank-Raue","year":"2011","journal-title":"Hum Mutat"},{"issue":"6","key":"10.1016\/j.beem.2025.101984_bib16","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1530\/EC-20-0163","article-title":"Primary hyperparathyroidism as first manifestation in multiple endocrine neoplasia type 2A: an international multicenter study","volume":"9","author":"Larsen","year":"2020","journal-title":"Endocr Connect"},{"issue":"2","key":"10.1016\/j.beem.2025.101984_bib17","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/s12020-020-02232-5","article-title":"100-Year evolution of precision medicine and surgery for multiple endocrine neoplasia type 2A","volume":"68","author":"Machens","year":"2020","journal-title":"Endocrine"},{"issue":"7","key":"10.1016\/j.beem.2025.101984_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15072125","article-title":"Primary hyperparathyroidism in Multiple Endocrine Neoplasia Type 2A in Denmark 1930-2021: a nationwide population-based retrospective study","volume":"15","author":"Holm","year":"2023","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.beem.2025.101984_bib19","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1007\/s002689900123","article-title":"Primary hyperparathyroidism in multiple endocrine neoplasia type IIa: retrospective French multicentric study. Groupe d\u2032Etude des Tumeurs a Calcitonine (GETC, French Calcitonin Tumors Study Group), French Association of Endocrine Surgeons","volume":"20","author":"Kraimps","year":"1996","journal-title":"World J Surg"},{"issue":"11","key":"10.1016\/j.beem.2025.101984_bib20","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1002\/jbmr.4677","article-title":"Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the Fifth International Workshop","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J Bone Min Res"},{"issue":"4","key":"10.1016\/j.beem.2025.101984_bib21","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2796.1995.tb01212.x","article-title":"Primary hyperparathyroidism in multiple endocrine neoplasia type 2A","volume":"238","author":"Raue","year":"1995","journal-title":"J Intern Med"},{"issue":"6","key":"10.1016\/j.beem.2025.101984_bib22","first-page":"1031","article-title":"Surgical management of primary hyperparathyroidism in multiple endocrine neoplasia types 1 and 2","volume":"114","author":"O'Riordain","year":"1993","journal-title":"Surgery"},{"issue":"12","key":"10.1016\/j.beem.2025.101984_bib23","doi-asserted-by":"crossref","first-page":"4534","DOI":"10.1210\/jc.2017-01249","article-title":"CDC73-related disorders: clinical manifestations and case detection in primary hyperparathyroidism","volume":"102","author":"van der Tuin","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2025.101984_bib24","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng1048","article-title":"HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome","volume":"32","author":"Carpten","year":"2002","journal-title":"Nat Genet"},{"issue":"3","key":"10.1016\/j.beem.2025.101984_bib25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/humu.21188","article-title":"Cell division cycle protein 73 homolog (CDC73) mutations in the hyperparathyroidism-jaw tumor syndrome (HPT-JT) and parathyroid tumors","volume":"31","author":"Newey","year":"2010","journal-title":"Hum Mutat"},{"issue":"12","key":"10.1016\/j.beem.2025.101984_bib26","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1002\/humu.23337","article-title":"Molecular genetics of syndromic and non-syndromic forms of parathyroid carcinoma","volume":"38","author":"Cardoso","year":"2017","journal-title":"Hum Mutat"},{"issue":"2","key":"10.1016\/j.beem.2025.101984_bib27","doi-asserted-by":"crossref","first-page":"E403","DOI":"10.1210\/jc.2012-2789","article-title":"Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidism","volume":"98","author":"Bricaire","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.beem.2025.101984_bib28","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1210\/clinem\/dgad368","article-title":"Phenotypic profiling and molecular mechanisms in hyperparathyroidism-jaw Tumor Syndrome","volume":"108","author":"Tora","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101984_bib29","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1761030","article-title":"Clinical features, treatment, and surveillance of Hyperparathyroidism-Jaw Tumor Syndrome: an up-to-date and review of the literature","volume":"2019","author":"Torresan","year":"2019","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.beem.2025.101984_bib30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejrad.2017.07.026","article-title":"The diagnostic accuracy of neck ultrasound, 4D-Computed tomographyand sestamibi imaging in parathyroid carcinoma","volume":"95","author":"Christakis","year":"2017","journal-title":"Eur J Radio"},{"issue":"6","key":"10.1016\/j.beem.2025.101984_bib31","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.surg.2014.08.004","article-title":"Hyperparathyroidism-jaw tumor syndrome: results of operative management","volume":"156","author":"Mehta","year":"2014","journal-title":"Surgery"},{"issue":"2","key":"10.1016\/j.beem.2025.101984_bib32","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s00268-019-05156-y","article-title":"Long-term outcomes of parathyroidectomy in hyperparathyroidism-Jaw Tumor Syndrome: analysis of five families with CDC73 mutations","volume":"44","author":"Iacobone","year":"2020","journal-title":"World J Surg"},{"issue":"9","key":"10.1016\/j.beem.2025.101984_bib33","first-page":"1005","article-title":"A germline mutation of HRPT2\/CDC73 (70 G>T) in an adolescent female with parathyroid carcinoma: first case report and a review of the literature","volume":"29","author":"Serrano-Gonzalez","year":"2016","journal-title":"J Pedia Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2025.101984_bib34","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/MPH.0000000000000443","article-title":"Parathyroid cancer in the pediatric patient","volume":"38","author":"Davidson","year":"2016","journal-title":"J Pedia Hematol Oncol"},{"key":"10.1016\/j.beem.2025.101984_bib35","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgae909","article-title":"Genotype-phenotype correlations in the hyperparathyroidism-Jaw Tumor Syndrome","author":"Simonds","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.beem.2025.101984_bib36","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00423-015-1342-7","article-title":"Hereditary hyperparathyroidism--a consensus report of the European Society of Endocrine Surgeons (ESES)","volume":"400","author":"Iacobone","year":"2015","journal-title":"Lange Arch Surg"},{"issue":"6","key":"10.1016\/j.beem.2025.101984_bib37","article-title":"Recent progress in molecular classification of phaeochromocytoma and paraganglioma","volume":"38","author":"Boehm","year":"2024","journal-title":"Best Pr Res Clin Endocrinol Metab"},{"issue":"11","key":"10.1016\/j.beem.2025.101984_bib38","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1210\/js.2017-00135","article-title":"Case report of a prolactinoma in a patient with a novel MAX mutation and bilateral pheochromocytomas","volume":"1","author":"Roszko","year":"2017","journal-title":"J Endocr Soc"},{"issue":"4","key":"10.1016\/j.beem.2025.101984_bib39","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1210\/clinem\/dgaa957","article-title":"Multiple endocrine tumors associated with germline MAX mutations: Multiple Endocrine Neoplasia Type 5?","volume":"106","author":"Seabrook","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.beem.2025.101984_bib40","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1158\/1078-0432.CCR-12-0160","article-title":"MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma","volume":"18","author":"Burnichon","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.beem.2025.101984_bib41","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgad136","article-title":"Germline and somatic inactivating FLCN variants in parathyroid cancer and atypical parathyroid tumors","author":"Jha","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101984_bib42","article-title":"A case of Birt Hogg Dube syndrome presented with parathyroid carcinoma","volume":"2","author":"Bektas","year":"2024","journal-title":"JCEM Case Rep"},{"key":"10.1016\/j.beem.2025.101984_bib43","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.gene.2017.09.044","article-title":"FLCN: the causative gene for Birt-Hogg-Dube syndrome","volume":"640","author":"Schmidt","year":"2018","journal-title":"Gene"},{"issue":"44","key":"10.1016\/j.beem.2025.101984_bib44","doi-asserted-by":"crossref","first-page":"18722","DOI":"10.1073\/pnas.0908853106","article-title":"Homozygous loss of BHD causes early embryonic lethality and kidney tumor development with activation of mTORC1 and mTORC2","volume":"106","author":"Hasumi","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.beem.2025.101984_bib45","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaf009","article-title":"FLCN variants in parathyroid carcinoma and atypical parathyroid tumors","volume":"9","author":"Burke","year":"2025","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.beem.2025.101984_bib46","article-title":"A rare soft tissue tumor masquerading as a parathyroid adenoma in a patient with birt-hogg-dube syndrome and multiple cervical endocrinopathies","volume":"2014","author":"Mikesell","year":"2014","journal-title":"Case Rep Pathol"},{"issue":"2","key":"10.1016\/j.beem.2025.101984_bib47","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s12022-023-09748-2","article-title":"FLCN-Driven functional adrenal cortical carcinoma with high mitotic tumor grade: extending the endocrine manifestations of birt-hogg-dube syndrome","volume":"34","author":"Hofstedter","year":"2023","journal-title":"Endocr Pathol"},{"issue":"1","key":"10.1016\/j.beem.2025.101984_bib48","first-page":"49","article-title":"Birt-Hogg-Dube Syndrome and coexistence with adrenocortical carcinoma","volume":"25","author":"Kalloniati","year":"2021","journal-title":"Hippokratia"},{"issue":"22","key":"10.1016\/j.beem.2025.101984_bib49","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003695","article-title":"Case report of birt-hogg-dube syndrome: germline mutations of FLCN detected in patients with renal cancer and thyroid cancer","volume":"95","author":"Dong","year":"2016","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.beem.2025.101984_bib50","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ajhg.2024.01.007","article-title":"Variants in ZFX are associated with an X-linked neurodevelopmental disorder with recurrent facial gestalt","volume":"111","author":"Shepherdson","year":"2024","journal-title":"Am J Hum Genet"},{"issue":"8","key":"10.1016\/j.beem.2025.101984_bib51","article-title":"A germline ZFX missense variant in a patient with primary hyperparathyroidism","volume":"2","author":"Guan","year":"2024","journal-title":"JCEM Case Rep"},{"issue":"5","key":"10.1016\/j.beem.2025.101984_bib52","doi-asserted-by":"crossref","first-page":"360","DOI":"10.18632\/oncoscience.38","article-title":"Recurrent ZFX mutations in human sporadic parathyroid adenomas","volume":"1","author":"Soong","year":"2014","journal-title":"Oncoscience"},{"issue":"5","key":"10.1016\/j.beem.2025.101984_bib53","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.beem.2018.05.004","article-title":"Familial hypocalciuric hypercalcemia and related disorders","volume":"32","author":"Lee","year":"2018","journal-title":"Best Pr Res Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2025.101984_bib54","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.beem.2018.09.010","article-title":"Management of familial hyperparathyroidism syndromes: MEN1, MEN2, MEN4, HPT-Jaw tumour, Familial isolated hyperparathyroidism, FHH, and neonatal severe hyperparathyroidism","volume":"32","author":"Cristina","year":"2018","journal-title":"Best Pr Res Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2025.101984_bib55","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.ajhg.2020.04.006","article-title":"Familial hypocalciuric hypercalcemia Type 1 and autosomal-dominant Hypocalcemia Type 1: prevalence in a large healthcare population","volume":"106","author":"Dershem","year":"2020","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.beem.2025.101984_bib56","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41574-018-0115-0","article-title":"The calcium-sensing receptor in physiology and in calcitropic and noncalcitropic diseases","volume":"15","author":"Hannan","year":"2018","journal-title":"Nat Rev Endocrinol"},{"issue":"26","key":"10.1016\/j.beem.2025.101984_bib57","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1056\/NEJMoa1300253","article-title":"Mutations affecting G-protein subunit alpha11 in hypercalcemia and hypocalcemia","volume":"368","author":"Nesbit","year":"2013","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.beem.2025.101984_bib58","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/jbmr.2778","article-title":"A G-protein Subunit-alpha11 loss-of-function mutation, Thr54Met, causes familial hypocalciuric hypercalcemia type 2 (FHH2)","volume":"31","author":"Gorvin","year":"2016","journal-title":"J Bone Min Res"},{"issue":"18","key":"10.1016\/j.beem.2025.101984_bib59","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1093\/hmg\/ddv226","article-title":"Adaptor protein-2 sigma subunit mutations causing familial hypocalciuric hypercalcaemia type 3 (FHH3) demonstrate genotype-phenotype correlations, codon bias and dominant-negative effects","volume":"24","author":"Hannan","year":"2015","journal-title":"Hum Mol Genet"},{"issue":"9","key":"10.1016\/j.beem.2025.101984_bib60","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1007\/s40618-024-02366-7","article-title":"Familial states of primary hyperparathyroidism: an update","volume":"47","author":"Cetani","year":"2024","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"10.1016\/j.beem.2025.101984_bib61","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/cen.14211","article-title":"Clinical characteristics of familial hypocalciuric hypercalcaemia type 1: a multicentre study of 77 adult patients","volume":"93","author":"Mouly","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.beem.2025.101984_bib62","article-title":"Recurrent pancreatitis in a patient with familial hypocalciuric hypercalcaemia treated successfully with cinacalcet","volume":"2014","author":"Gunganah","year":"2014","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"5","key":"10.1016\/j.beem.2025.101984_bib63","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1210\/jc.2015-3442","article-title":"Familial hypocalciuric hypercalcemia types 1 and 3 and primary hyperparathyroidism: similarities and differences","volume":"101","author":"Vargas-Poussou","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2025.101984_bib64","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/0002-9343(84)90852-0","article-title":"Parathyroid glands in familial benign hypercalcemia (familial hypocalciuric hypercalcemia)","volume":"76","author":"Law","year":"1984","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.beem.2025.101984_bib65","doi-asserted-by":"crossref","first-page":"L29","DOI":"10.1210\/jc.2014-4221","article-title":"Letter to the editor: distinguishing typical primary hyperparathyroidism from familial hypocalciuric hypercalcemia by using an index of urinary calcium","volume":"100","author":"Marx","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.beem.2025.101984_bib66","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1530\/EJE-21-1044","article-title":"European expert consensus on practical management of specific aspects of parathyroid disorders in adults and in pregnancy: recommendations of the ESE educational program of parathyroid disorders","volume":"186","author":"Bollerslev","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.beem.2025.101984_bib67","article-title":"Familial hypocalciuric hypercalcemia in pregnancy: diagnostic pitfalls","volume":"4","author":"Jones","year":"2020","journal-title":"JBMR"},{"issue":"1","key":"10.1016\/j.beem.2025.101984_bib68","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/jbmr.3241","article-title":"Cinacalcet rectifies hypercalcemia in a patient with familial hypocalciuric hypercalcemia type 2 (FHH2) caused by a germline loss-of-function galpha(11) mutation","volume":"33","author":"Gorvin","year":"2018","journal-title":"J Bone Min Res"},{"issue":"3","key":"10.1016\/j.beem.2025.101984_bib69","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1172\/JCI117062","article-title":"Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype","volume":"93","author":"Pollak","year":"1994","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.beem.2025.101984_bib70","doi-asserted-by":"crossref","first-page":"352","DOI":"10.5144\/0256-4947.2023.01.11.1200","article-title":"Surgical management of neonatal severe hyperparathyroidism","volume":"43","author":"Alshanafey","year":"2023","journal-title":"Ann Saudi Med"},{"issue":"4","key":"10.1016\/j.beem.2025.101984_bib71","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1210\/clinem\/dgz233","article-title":"Neonatal severe hyperparathyroidism: novel insights from calcium, PTH, and the CASR gene","volume":"105","author":"Marx","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101984_bib72","article-title":"Successful treatment of neonatal severe hyperparathyroidism with cinacalcet in two patients","volume":"2015","author":"Fisher","year":"2015","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"issue":"1","key":"10.1016\/j.beem.2025.101984_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210662","article-title":"Gcm2 regulates the maintenance of parathyroid cells in adult mice","volume":"14","author":"Yamada","year":"2019","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.beem.2025.101984_bib74","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1530\/EJE-21-0433","article-title":"Novel Glial Cells Missing-2 (GCM2) variants in parathyroid disorders","volume":"186","author":"Canaff","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"10.1016\/j.beem.2025.101984_bib75","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1172\/JCI200113180","article-title":"Familial isolated hypoparathyroidism caused by a mutation in the gene for the transcription factor GCMB","volume":"108","author":"Ding","year":"2001","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.beem.2025.101984_bib76","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1038\/s41598-021-82661-y","article-title":"Five patients with disorders of calcium metabolism presented with GCM2 gene variants","volume":"11","author":"Garcia-Castano","year":"2021","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.beem.2025.101984_bib77","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ajhg.2016.08.018","article-title":"GCM2-activating mutations in familial isolated hyperparathyroidism","volume":"99","author":"Guan","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.beem.2025.101984_bib78","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1210\/js.2017-00043","article-title":"Ethnicity of patients with germline GCM2-activating variants and primary hyperparathyroidism","volume":"1","author":"Guan","year":"2017","journal-title":"J Endocr Soc"},{"issue":"12","key":"10.1016\/j.beem.2025.101984_bib79","doi-asserted-by":"crossref","first-page":"E2794","DOI":"10.1210\/jc.2014-2857","article-title":"Increased prevalence of the GCM2 polymorphism, Y282D, in primary hyperparathyroidism: analysis of three Italian cohorts","volume":"99","author":"D'Agruma","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2025.101984_bib80","article-title":"GCM2 Variants in Familial and Multiglandular Primary Hyperparathyroidism","author":"Vincze","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2025.101984_bib81","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1530\/EJE-19-0641","article-title":"Should the GCM2 gene be tested when screening for familial primary hyperparathyroidism?","volume":"182","author":"Coppin","year":"2020","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"10.1016\/j.beem.2025.101984_bib82","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1210\/jc.2018-02517","article-title":"Analysis of activating GCM2 sequence variants in sporadic parathyroid adenomas","volume":"104","author":"Riccardi","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2025.101984_bib83","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.surg.2017.04.027","article-title":"Familial isolated primary hyperparathyroidism associated with germline GCM2 mutations is more aggressive and has a lesser rate of biochemical cure","volume":"163","author":"El Lakis","year":"2018","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.beem.2025.101984_bib84","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.ajhg.2018.04.006","article-title":"TRPV6 variants interfere with maternal-fetal calcium transport through the placenta and cause transient neonatal hyperparathyroidism","volume":"102","author":"Suzuki","year":"2018","journal-title":"Am J Hum Genet"},{"issue":"9","key":"10.1016\/j.beem.2025.101984_bib85","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1002\/ajmg.a.40484","article-title":"TRPV6 compound heterozygous variants result in impaired placental calcium transport and severe undermineralization and dysplasia of the fetal skeleton","volume":"176","author":"Burren","year":"2018","journal-title":"Am J Med Genet A"},{"issue":"2","key":"10.1016\/j.beem.2025.101984_bib86","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1359\/jbmr.061110","article-title":"Marked disturbance of calcium homeostasis in mice with targeted disruption of the Trpv6 calcium channel gene","volume":"22","author":"Bianco","year":"2007","journal-title":"J Bone Min Res"},{"issue":"1","key":"10.1016\/j.beem.2025.101984_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005792-200201000-00001","article-title":"Familial isolated hyperparathyroidism: clinical and genetic characteristics of 36 kindreds","volume":"81","author":"Simonds","year":"2002","journal-title":"Med (Baltim)"},{"issue":"2","key":"10.1016\/j.beem.2025.101984_bib88","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s40618-019-01107-5","article-title":"Whole exome sequencing in familial isolated primary hyperparathyroidism","volume":"43","author":"Cetani","year":"2020","journal-title":"J Endocrinol Invest"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X2500017X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X2500017X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T06:53:08Z","timestamp":1741935188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X2500017X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":88,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1521690X2500017X"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2025.101984","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heritable hyperparathyroidism: Genetic insights and clinical implications","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2025.101984","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101984"}}